Abstract
Tuberous sclerosis is the second most common neurocutaneous syndrome after neurofibromatosis. The term “tuberous sclerosis” derived from the “tubers” (swellings or protuberances) and areas of “sclerosis” (hardening) of the cerebral gyri that calcifies with age. The classic description of the syndrome includes Bogt’s triad: mental retardation, seizures, and adenoma sebaceum (a misnomer) or facial angiofibromas. Tuberous sclerosis affects about one in 6000 newborns.
Preview
Unable to display preview. Download preview PDF.
References
Al-Saleem T, Wessner LL, Scheithauer BW, et al.: Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer 83:2208–2216, 1998.
Alcorn DM: Phacomatoses for the general ophthalmologist. Ophthalmol Clin N Am 12:243–253, 1999.
Ali JB, Sepp T, Ward S, et al.: Mutations in the TSC1 gene account for a minority of patients with tuberous sclerosis. J Med Genet 35:969–972, 1998.
Altman NR, Purser RK, Post MJ: Tuberous sclerosis: characteristics at CT and MR imaging. Radiology 167:527–532, 1988.
Au K-S, Pollom GJ, Roach ES, et al.: TSC1 and TSC2 gene mutations: detection and genotype/phenotype correlation. Am J Hum Genet 63(S):350, 1998.
Au KS, Rodriguez JA, Finch JL, et al.: Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients. Am J Hum Genet 62:286–294, 1998.
Avellino AM, Berger MS, Rostomily RC, et al.: Surgical management and seizure outcome in patients with tuberous sclerosis. J Neurosurg 87:391–396, 1997.
Bader RS, Chitayat D, Kelly E, et al.: Fetal rhabdomyoma: prenatal diagnosis, clinical outcome, and incidence of associated tuberous sclerosis complex. J Pediatr 143:620–624, 2003.
Baker P, Piven J, Sato Y: Autism and tuberous sclerosis complex: prevalence and clinical features. J Autism Dev Disord 28:279–285, 1998.
Baron Y, Barkovich AJ: MR imaging of tuberous sclerosis in neonates and young infants. AJNR Am J Neuroradiol 20:907–916, 1999.
Barron RP, Kainulainen VT, Forrest CR, et al.: Tuberous sclerosis: clinicopathologic features and review of the literature. J Craniomaxillofac Surg 30:361–366, 2002.
Baumgartner JE, Wheless JW, Kulkarni S, et al.: On the surgical treatment of refractory epilepsy in tuberous sclerosis complex. Pediatr Neurosurg 27:311–318, 1997.
Benvenuto G, Li S, Brown SJ, et al.: The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene 19:6306–6316, 2000.
Bernauer TA, Mirowski GW, Caldemeyer KS: Tuberous sclerosis. Part II. Musculoskeletal and visceral findings. J Am Acad Dermatol 45:450–452, 2001.
Brook-Carter PT, Peral B, Ward CJ, et al.: Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease—a contiguous gene syndrome. Nat Genet 8:328–332, 1994.
Caldemeyer KS, Mirowski GW: Tuberous sclerosis. Part I. Clinical and central nervous system findings. J Am Acad Dermatol 45:448–449, 2001.
Carbonara C, Longa L, Grosso E, et al.: Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas. Genes Chromosomes Cancer 15:18–25, 1996.
Cassidy SB, Pagon RA, Pepin M, et al.: Family studies in tuberous sclerosis. Evaluation of apparently unaffected parents. J Am Med Assoc 249:1302–1304, 1983.
Crino PB, Henske EP: New developments in the neurobiology of the tuberous sclerosis complex. Am Acad Neurol 53:1384–1390, 1999.
Curatolo P, Cusmai R, Cortesi F, et al.: Neuropsychiatric aspects of tuberous sclerosis. Ann N Y Acad Sci 615:8–16, 1991.
Dabora SL, Jozwiak S, Franz DN, et al.: Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 68:64–80, 2001.
Ewalt DH, Sheffield E, Sparagana SP, et al.: Renal lesion growth in children with tuberous sclerosis complex. J Urol 160:141–145, 1998.
Fitzpatrick TB: History and significance of white macules, earliest visible sign of tuberous sclerosis. Ann N Y Acad Sci 615:26–35, 1991.
Franz DN: Diagnosis and management of tuberous sclerosis complex. Semin Pediatr Neurol 5:253–268, 1998.
Franz DN, Glauser TA: Tuberous sclerosis. eMedicine, 2002.
Fryer AE, Chalmers A, Connor JM, et al.: Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet 1:659–661, 1987.
Gibbs JL: The heart and tuberous sclerosis. An echocardiographic and electrocardiographic study. Br Heart J 54:596–599, 1985.
Gillberg IC, Gillberg C, Ahlsen G: Autistic behaviour and attention deficits in tuberous sclerosis: a population-based study. Dev Med Child Neurol 36:50–56, 1994.
Gomez MR: Tuberous Sclerosis, 2 ed. Raven Press, New York, 1988.
Gomez MR: Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria. Ann N Y Acad Sci 615:1–7, 1991.
Goodman M, Lamm SH, Engel A, et al.: Cortical tuber count: a biomarker indicating neurologic severity of tuberous sclerosis complex. J Child Neurol 12:85–90, 1997.
Green AJ, Smith M, Yates JR: Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 6:193–196, 1994.
Gutierrez GC, Smalley SL, Tanguay PE: Autism in tuberous sclerosis complex. J Autism Dev Disord 28:97–103, 1998.
Haines JL, Short MP, Kwiatkowski DJ, et al.: Localization of one gene for tuberous sclerosis within 9q32–9q34, and further evidence for heterogeneity. Am J Hum Genet 49:764–772, 1991.
Hancock E, Osborne JP: Vigabatrin in the treatment of infantile spasms in tuberous sclerosis. Literature review. J Child Neurol 14:71–74, 1999.
Henske EP, Neumann HP, Scheithauer BW, et al.: Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer 13:295–298, 1995.
Houser OW, Shepherd CW, Gomez MR: Imaging of intracranial tuberous sclerosis. Ann N Y Acad Sci 615:81–93, 1991.
Hunt A, Dennis J: Psychiatric disorder among children with tuberous sclerosis. Dev Med Child Neurol 29:190–198, 1987.
Hurst JS, Wilcoski S: Recognizing an index case of tuberous sclerosis. Am Fam Physician 61:703–708, 2000.
Jarrar RG, Buchhalter JR, Raffel C: Long-term outcome of epilepsy surgery in patients with tuberous sclerosis. Neurology 62:479–481, 2004.
Johnson CL, Pedersen R: Tuberous sclerosis. eMedicine 2002.
Jones AC, Daniells CE, Snell RG, et al.: Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum Mol Genet 6:2155–2161, 1997.
Jones AC, Shyamsundar MM, Thomas MW, et al.: Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 64:1305–1315, 1999.
Jozwiak S, Kawalec W, Dluzewska J, et al.: Cardiac tumours in tuberous sclerosis: their incidence and course. Eur J Pediatr 153:155–157, 1994.
Kandt RS, Haines JL, Smith M, et al.: Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 2:37–41, 1992.
Lendvay TS, Marshall FF: The tuberous sclerosis complex and its highly variable manifestations. J Urol 169:1635–1642, 2003.
Levine D, Barnes P, Korf B, et al.: Tuberous sclerosis in the fetus. Second-trimester diagnosis of subependymal tubers with ultrafast MR imaging. Am J Roentgenol 175:1067–1069, 2000.
Martignoni G, Pea M, Rocca PC, et al.: Renal pathology in the tuberous sclerosis complex. Pathology 35:505–512, 2003.
Mitchell AL, Parisi MA, Sybert VP: Effects of pregnancy on the renal and pulmonary manifestations in women with tuberous sclerosis complex. Genet Med 5:154–160, 2003.
Muller RF: Tuberous sclerosis. In: Cassidy SB, Allanson JE (eds): Management of Genetic Syndromes. New York: Wiley-Liss, 2001.
Nambi R: Tuberous sclerosis. eMedicine 2001.
Nevin NC, Pearce WG: Diagnostic and genetical aspects of tuberous sclerosis. J Med Genet 5:273–280, 1968.
Northrup H: Tuberous sclerosis complex. Gene Reviews, 2002.
Northrup H, Wheless JW, Bertin TK, et al.: Variability of expression in tuberous sclerosis. J Med Genet 30:41–43, 1993.
O’Callaghan FJ, Osborne JP: Advances in the understanding of tuberous sclerosis. Arch Dis Child 83:140–142, 2000.
Osborne JP, Fryer A, Webb D: Epidemiology of tuberous sclerosis. Ann NY Acad Sci 615:125–127, 1991.
Papaioannou EG, Staikou CV, Lambadarioui A, et al.: Anesthetic management of a patient with tuberous sclerosis presenting for renal transplantation. J Anesth 17:193–195, 2003.
Roach ES, Smith M, Huttenlocher P, Bhat M, Alcorn D, Hawley L: Report of the Diagnostic Criteria Committee of the National Tuberous Sclerosis Association. J Child Neurol 7:221–224, 1992.
Roach ES, Gomez MR, Northrup H: Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 13:624–628, 1998.
Roach ES, DiMario FJ, Kandt RS, et al.: Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association. J Child Neurol 14:401–407, 1999.
Rose VM, Au KS, Pollom G, et al.: Germ-line mosaicism in tuberous sclerosis: how common? Am J Hum Genet 64:986–992, 1999.
Sampson JR, Maheshwar MM, Aspinwall R, et al.: Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet 61:843–851, 1997.
Shepherd CW, Gomez MR, Lie JT, et al.: Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 66:792–796, 1991.
Smith HC, Watson GH, Patel RG, et al.: Cardiac rhabdomyomata in tuberous sclerosis: their course and diagnostic value. Arch Dis Child 64:196–200, 1989.
Stillwell TJ, Gomez MR, Kelalis PP: Renal lesions in tuberous sclerosis. J Urol 138:477–481, 1987.
Strizheva GD, Carsillo T, Kruger WD, et al.: The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis. Am J Respir Crit Care Med 163:253–258, 2001.
Tekin M, Bodurtha JN, Riccardi VM: Café au lait spots: The pediatrician’s perspective. Pediatr Rev 22:82–90, 2001.
The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305–1315, 1993.
Trauner MA, Ruben BS, Lynch PJ: Segmental tuberous sclerosis presenting as unilateral facial angiofibromas. J Am Acad Dermatol 49:S164–166, 2003.
Tworetzky W, McElhinney DB, Margossian R, et al.: Association between cardiac tumors and tuberous sclerosis in the fetus and neonate. Am J Cardiol 92:487–489, 2003.
van Slegtenhorst M, de Hoogt R, Hermans C, et al.: Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805–808, 1997.
van Slegtenhorst M, Nellist M, Nagelkerken B, et al.: Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 7:1053–1057, 1998.
Verhoef S, Bakker L, Tempelaars AM, et al.: High rate of mosaicism in tuberous sclerosis complex. Am J Hum Genet 64:1632–1637, 1999.
Vicente MP, Pons M, Medina M: Pulmonary involvement in tuberous sclerosis. Pediatr Pulmonol 37:178–180, 2004.
Weiner DM, Ewalt DH, Roach ES, et al.: The tuberous sclerosis complex: a comprehensive review. J Am Coll Surg 187:548–561, 1998.
Yeung RS: Tuberous sclerosis as an underlying basis for infantile spasm. Int Rev Neurobiol 49:315–332, 2002.
Yeung RS: Multiple roles of the tuberous sclerosis complex genes. Genes Chromosomes Cancer 38:368–375, 2003.
Young JM, Burley MW, Jeremiah SJ, et al.: A mutation screen of the TSC1 gene reveals 26 protein truncating mutations and 1 splice site mutation in a panel of 79 tuberous sclerosis patients. Ann Hum Genet 62 (Pt 3):203–213, 1998.
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this chapter
Cite this chapter
(2006). Tuberous Sclerosis. In: Atlas of Genetic Diagnosis and Counseling. Humana Press. https://doi.org/10.1007/978-1-60327-161-5_189
Download citation
DOI: https://doi.org/10.1007/978-1-60327-161-5_189
Publisher Name: Humana Press
Print ISBN: 978-1-58829-681-8
Online ISBN: 978-1-60327-161-5
eBook Packages: MedicineMedicine (R0)